Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

LG Energy Solution / Equity Capital Markets

<ul>
<li><strong>Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. </strong></li>
<li>Trading debuts across different markets have been poor. But there are some trades to be put for lock-up expiries.</li>
<li>This will be our last week of ECM weekly notes for the year. Our weekly notes will be back in January when things start to pick up again.</li>
</ul>


Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. 
Trading debuts across different markets have been poor. But there are some trades to be put for lock-up expiries.
This will be our last week of ECM weekly notes for the year. Our weekly notes will be back in January when things start to pick up again.


ECM Weekly (19th December 2021) - LG Energy, Hyundai Engineering, Chervon, Sirnaomics, JG Mag A/H

APAC IPOs & Placements, Aequitas Research

Clarence Chu

APAC IPOs & Placements

Sahajanand Medical Technologies Ltd / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/sahajanand-medical-technologies-ltd" target="_blank" data-smartkarma-citation="entities:35324:1" rel="noopener">Sahajanand Medical Technologies Ltd (544309Z IN)</a> is looking to raise US$202m in its upcoming India IPO. The deal will be run by Axis Capital, Bank of America, Edelweiss and UBS.</li>
<li>Sahajanand Medical Technologies is a medical devices company that researches, designs, develops, manufactures and markets vascular devices.</li>
<li>The product portfolio is led by its flagship coronary stent, Supraflex Cruz, where the product had been implanted in over 400,000 patients globally as of Mar 2021.</li>
</ul>



Sahajanand Medical Technologies Ltd (544309Z IN) is looking to raise US$202m in its upcoming India IPO. The deal will be run by Axis Capital, Bank of America, Edelweiss and UBS.
Sahajanand Medical Technologies is a medical devices company that researches, designs, develops, manufactures and markets vascular devices.
The product portfolio is led by its flagship coronary stent, Supraflex Cruz, where the product had been implanted in over 400,000 patients globally as of Mar 2021.


Sahajanand Medical Technologies Pre-IPO Tearsheet

India

Sahajanand Medical Technologies Private Limited manufactures medical equipment. The Company offers drug eluting, bare metal stents, balloon catheters, and inflation devices. Sahajanand Medical Technologies serves customers worldwide.

Sahajanand Medical Technologies Ltd (544309Z IN)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

ECM Weekly (19th December 2021) - LG Energy, Hyundai Engineering, Chervon, Sirnaomics, JG Mag A/H

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Sumeet Singh

Sahajanand Medical Technologies Pre-IPO Tearsheet

Sahajanand Medical Technologies Ltd (544309Z IN) is looking to raise US$202m in its upcoming India IPO. The deal will be run by Axis Capital, Bank...

Clarence Chu